Correlation Between Trustcash Holdings and Rigel Pharmaceuticals
Can any of the company-specific risk be diversified away by investing in both Trustcash Holdings and Rigel Pharmaceuticals at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Trustcash Holdings and Rigel Pharmaceuticals into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Trustcash Holdings and Rigel Pharmaceuticals, you can compare the effects of market volatilities on Trustcash Holdings and Rigel Pharmaceuticals and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Trustcash Holdings with a short position of Rigel Pharmaceuticals. Check out your portfolio center. Please also check ongoing floating volatility patterns of Trustcash Holdings and Rigel Pharmaceuticals.
Diversification Opportunities for Trustcash Holdings and Rigel Pharmaceuticals
-0.97 | Correlation Coefficient |
Pay attention - limited upside
The 3 months correlation between Trustcash and Rigel is -0.97. Overlapping area represents the amount of risk that can be diversified away by holding Trustcash Holdings and Rigel Pharmaceuticals in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Rigel Pharmaceuticals and Trustcash Holdings is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Trustcash Holdings are associated (or correlated) with Rigel Pharmaceuticals. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Rigel Pharmaceuticals has no effect on the direction of Trustcash Holdings i.e., Trustcash Holdings and Rigel Pharmaceuticals go up and down completely randomly.
Pair Corralation between Trustcash Holdings and Rigel Pharmaceuticals
Given the investment horizon of 90 days Trustcash Holdings is expected to under-perform the Rigel Pharmaceuticals. In addition to that, Trustcash Holdings is 2.23 times more volatile than Rigel Pharmaceuticals. It trades about -0.23 of its total potential returns per unit of risk. Rigel Pharmaceuticals is currently generating about 0.35 per unit of volatility. If you would invest 1,407 in Rigel Pharmaceuticals on September 4, 2024 and sell it today you would earn a total of 1,298 from holding Rigel Pharmaceuticals or generate 92.25% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Against |
| Strength | Significant |
| Accuracy | 90.48% |
| Values | Daily Returns |
Trustcash Holdings vs. Rigel Pharmaceuticals
Performance |
| Timeline |
| Trustcash Holdings |
| Rigel Pharmaceuticals |
Trustcash Holdings and Rigel Pharmaceuticals Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Trustcash Holdings and Rigel Pharmaceuticals
The main advantage of trading using opposite Trustcash Holdings and Rigel Pharmaceuticals positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Trustcash Holdings position performs unexpectedly, Rigel Pharmaceuticals can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Rigel Pharmaceuticals will offset losses from the drop in Rigel Pharmaceuticals' long position.| Trustcash Holdings vs. Atos SE | Trustcash Holdings vs. Deveron Corp | Trustcash Holdings vs. Appen Limited | Trustcash Holdings vs. Atos Origin SA |
| Rigel Pharmaceuticals vs. Fortress Biotech | Rigel Pharmaceuticals vs. Reviva Pharmaceuticals Holdings | Rigel Pharmaceuticals vs. Pieris Pharmaceuticals | Rigel Pharmaceuticals vs. Cidara Therapeutics |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Fundamentals Comparison module to compare fundamentals across multiple equities to find investing opportunities.
Other Complementary Tools
| Competition Analyzer Analyze and compare many basic indicators for a group of related or unrelated entities | |
| Economic Indicators Top statistical indicators that provide insights into how an economy is performing | |
| Insider Screener Find insiders across different sectors to evaluate their impact on performance | |
| Price Transformation Use Price Transformation models to analyze the depth of different equity instruments across global markets | |
| USA ETFs Find actively traded Exchange Traded Funds (ETF) in USA |